NCT04411875View on ClinicalTrials.gov

Bioequivalence of Levamlodipine Besylate Tablets in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 13, 2018

Primary Completion Date

January 15, 2019

Study Completion Date

February 15, 2019

Conditions
Healthy Subjects
Interventions
DRUG

Amlodipine 10 mg

The subjects randomly received single oral administration of amlodipine 10 mg.

DRUG

Levamlodipine 5 mg

The subjects randomly received single oral administration of levamlodipine 5 mg.

Trial Locations (1)

266003

Phase Ⅰ Clinical Research Center, Qingdao

All Listed Sponsors
lead

The Affiliated Hospital of Qingdao University

OTHER

NCT04411875 - Bioequivalence of Levamlodipine Besylate Tablets in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter